BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based ...

The INEC recognition comes amid claims by some aggrieved members of the ADC who have questioned the authenticity of the Mark-led leadership. Despite strong opposition, INEC recognises David Mark's ...

Investors in Agree Realty Corp. (Symbol: ADC) saw new options become available today, for the November 21st expiration. One of the key data points that goes into the price an option buyer is willing ...

Log in to download the PDF of this article on the key role of digital controllers in myriad systems, and determining ADC and DAC performance in these systems. Digital ...

Since its formation in 2005, the African Democratic Congress (ADC) has never been a force to reckon with as a political party. It is more of a vehicle which utility value can only be guaranteed for ...

While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...

TegMine Therapeutics has secured certain rights to OBI Pharma’s antibody-drug conjugate technology, advancing the efforts of former Stemcentrx scientists to treat cancer by targeting carbohydrates.

A pooled analysis of JSKN003, a biparatopic anti-HER2 antibody conjugate (ADC), in patients with advanced HER2-overexpressing (IHC 3+) gastrointestinal tumors. This is an ASCO Meeting Abstract from ...

A phase 1 study to evaluate the safety and tolerability of the antibody–drug conjugate (ADC) MesoC2 (PF-08052666) in patients with advanced solid tumors. This is an ASCO Meeting Abstract from the 2025 ...

After flexing its antibody-drug conjugate bona fides at last year’s American Society of Clinical Oncology (ASCO) conference, AbbVie is advancing its solid tumor ambitions with a new FDA green light.